Myeloid p38 activation maintains macrophage–liver crosstalk and BAT thermogenesis through IL‐12–FGF21 axis
Hepatology · 2023-03 · 77 (3) · 874-887
DOI: 10.1002/hep.32581 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hepatology, online erschienen am 17.02.2023. Verfasst von María Crespo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Centro Nacional de Investigaciones Cardiovasculares , Madrid , Spain. Hauptthemen laut MEDLINE: Fatty Liver, Insulin Resistance. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Obesity features excessive fat accumulation in several body tissues and induces a state of chronic low‐grade inflammation that contributes to the development of diabetes, steatosis, and insulin resistance. Recent research has shown that this chronic inflammation is crucially dependent on p38 pathway activity in macrophages, suggesting p38 inhibition as a possible treatment for obesity comorbidities. Nevertheless, we report here that lack of p38 activation in myeloid cells worsens high‐fat diet–induced obesity, diabetes, and steatosis. Deficient p38 activation increases macrophage IL‐12 production, leading to inhibition of hepatic FGF21 and reduction of thermogenesis in the brown fat. The implication of FGF21 in the phenotype was confirmed by its specific deletion in hepatocytes. We also found that IL‐12 correlates with liver damage in human biopsies, indicating the translational potential of our results. Our findings suggest that myeloid p38 has a dual role in inflammation and that drugs targeting IL‐12 might improve the homeostatic regulation of energy balance in response to metabolic stress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centro Nacional de Investigaciones Cardiovasculares , Madrid , Spain.
- Departamento de Ciencias Básicas de la Salud, Área de Bioquímica y Biología Molecular, Lipobeta group , Universidad Rey Juan Carlos , Madrid , Spain.
- Laboratorio LAFEMEX, Área de Bioquímica y Biología Molecular, Departamento de Ciencias Básicas de la Salud, Facultad de Ciencias de la Salud , Universidad Rey Juan Carlos , Madrid , Spain.
- Department of General Surgery , University Hospital of Salamanca-IBSAL , Salamanca , Spain.
- Department of Surgery , University of Salamanca , Salamanca , Spain.
- Department of Internal Medicine , University Hospital of Salamanca-Institute of Biomedical Research of Salamanca (IBSAL) , Salamanca , Spain.
ORCID-Profile: Alfonso Mora, Guadalupe Sabio
Zitieren
APA
Crespo, M., Nikolic, I., Mora, A., Rodríguez, E., Leiva-Vega, L., Pintor-Chocano, A., Horrillo, D., Hernández-Cosido, L., Torres, J. L., Novoa, E., Nogueiras, R., Medina-Gómez, G., Marcos, M., Leiva, M., & Sabio, G. (2023). Myeloid p38 activation maintains macrophage–liver crosstalk and BAT thermogenesis through IL‐12–FGF21 axis. Hepatology, 77(3), 874-887. https://doi.org/10.1002/hep.32581
Vancouver
Crespo M, Nikolic I, Mora A, Rodríguez E, Leiva-Vega L, Pintor-Chocano A, et al. Myeloid p38 activation maintains macrophage–liver crosstalk and BAT thermogenesis through IL‐12–FGF21 axis. Hepatology. 2023;77(3):874-887. doi:10.1002/hep.32581
BibTeX
@article{Crespo2023,
author = {Crespo, María and Nikolic, Ivana and Mora, Alfonso and Rodríguez, Elena and Leiva-Vega, Luis and Pintor-Chocano, Aránzazu and Horrillo, Daniel and Hernández-Cosido, Lourdes and Torres, Jorge L and Novoa, Eva and Nogueiras, Rubén and Medina-Gómez, Gema and Marcos, Miguel and Leiva, Magdalena and Sabio, Guadalupe},
title = {Myeloid p38 activation maintains macrophage–liver crosstalk and BAT thermogenesis through IL‐12–FGF21 axis},
journal = {Hepatology},
year = {2023},
volume = {77},
number = {3},
pages = {874--887},
doi = {10.1002/hep.32581}
}
EUVIMED